Alterations in cholesterol metabolism as a risk factor for developing Alzheimer’s disease: Potential novel targets for treatment
Open Access
- 1 June 2019
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 190, 104-114
Abstract
No abstract availableKeywords
Funding Information
- Margaretha Af Ugglas Foundation, Stonhes Foundation and Foundation of Old Servants, the Swedish Medical Foundation
- Lindhés Advokatbyrå AB Foundation
- Karolinska Institutet Foundation for Research
- Swedish Research Council and StratNeuro
This publication has 165 references indexed in Scilit:
- Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterolCellular Signalling, 2012
- PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2Nature Neuroscience, 2012
- Cholesterol Level and Statin Use in Alzheimer DiseaseArchives of Neurology, 2011
- 27-Hydroxycholesterol: the first identified endogenous SERMTrends in Endocrinology & Metabolism, 2011
- Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related DisordersBiological Psychiatry, 2010
- Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's DiseaseMolecular Therapy, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2009
- Alzheimer's diseaseThe Lancet, 2006
- Protein Sensors for Membrane SterolsCell, 2006